CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Akebia Therapeutics, Inc.  (AKBA)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Akebia Therapeutics's Gross Margin by quarter

Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

AKBA Gross Margin (Jun 30 2017)
II. Quarter
(Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
Y / Y Revenue Change - - - - -
Y / Y Gross Profit Change - - - - -
Gross Margin - - - - -
Gross Margin Total Ranking # 520 # 57 # 54 # 54 # 0
Seq. Revenue Change 36.69 % 1259.28 % - - -
Seq. Gross Profit Change - - - - -


Commenting Second Quarter 2017 Gross Margin
Akebia Therapeutics has managed to improve its Revenue sequentially to $29 millions by 36.69 % faster than Gross Profit increase of 36.69 % to $29 millions, this led to contraction in Gross Margin to 100 %, a new company low.

Observing second quarter 2017 results within Major Pharmaceutical Preparations industry 62 other companies have achieved higher Gross Margin. While overall Gross Margin ranking remained unchanged compare to previous quarter at no. .
Learn about Gross Margin
AKBA's Gross Margin second quarter 2017 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 63
Healthcare Sector # 138
Overall # 520

Gross Margin Statistics
High Average Low
100 % 100 % 100 %
(Jun 30 2017)  

You need to upgrade your Flash Player


Financial Statements
Akebia Therapeutics's (Jun 30 2017) Gross Profit $ 29 AKBA's Income Statement
Akebia Therapeutics's (Jun 30 2016) Gross Profit $ 0 Quarterly AKBA's Growth
AKBA's Profits by Division See AKBA's Profits by Segment

Other Gross Margin Profitability Ratios
AKBA's Cumulative Gross Margin
Major Pharmaceutical Preparations Industry Gross Margin Trends and Statistics
Healthcare Sector Gross Margin Statistics
Gross Margin Profitability Trends for overall market
AKBA's Gross Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Margin
Lowest Ranking Gross Margin
Gross Margin Profit Margin for AKBA's Competitors
Gross Margin Profit Margin for Akebia Therapeutics's Suppliers
Gross Margin Profit Margin for AKBA's Customers

You may also want to know
AKBA's Annual Growth Rates AKBA's Profitability Ratios AKBA's Asset Turnover Ratio AKBA's Dividend Growth
AKBA's Roe AKBA's Valuation Ratios AKBA's Financial Strength Ratios AKBA's Gross Profit Growth
AKBA's Roa AKBA's Inventory Turnover Ratio AKBA's Growth Rates AKBA's Dividend Comparisons


Companies with similar Gross Margin in the quarter ending Jun 30 2017, within Major Pharmaceutical Preparations Industry Gross MarginJun 30 2017 MRQ Gross ProfitJun 30 2017 MRQ Revenue
Karyopharm Therapeutics Inc.  100.00 %$ 0.003 $ 0.003 
Kalvista Pharmaceuticals, Inc.  100.00 %$ 0.096 $ 0.096 
Abeona Therapeutics Inc.  100.00 %$ 0.217 $ 0.217 
Intra-cellular Therapies, Inc.  100.00 %$ 0.115 $ 0.115 
Seres Therapeutics, Inc.  100.00 %$ 3.014 $ 3.014 
Macrogenics Inc  100.00 %$ 1.666 $ 1.666 
Northwest Biotherapeutics Inc  100.00 %$ 0.088 $ 0.088 
Novan, Inc.  100.00 %$ 0.669 $ 0.669 
Newlink Genetics Corp  100.00 %$ 10.370 $ 10.370 
Nabriva Therapeutics Plc  100.00 %$ 1.051 $ 1.051 
Ionis Pharmaceuticals Inc  100.00 %$ 104.152 $ 104.152 
Immunogen Inc  100.00 %$ 39.020 $ 39.020 
Epizyme, Inc.  100.00 %$ 10.000 $ 10.000 
Enanta Pharmaceuticals Inc  100.00 %$ 7.511 $ 7.511 
Endocyte Inc  100.00 %$ 0.013 $ 0.013 
Dynavax Technologies Corp  100.00 %$ 0.105 $ 0.105 
Evoke Pharma Inc  100.00 %$ 1.262 $ 1.262 
Eyegate Pharmaceuticals Inc  100.00 %$ 0.148 $ 0.148 
Ibio, Inc.  100.00 %$ 0.147 $ 0.147 
Heat Biologics, Inc.  100.00 %$ 0.411 $ 0.411 
Five Prime Therapeutics Inc  100.00 %$ 7.822 $ 7.822 
Fibrogen Inc  100.00 %$ 28.997 $ 28.997 
Oncomed Pharmaceuticals Inc  100.00 %$ 6.195 $ 6.195 
Onconova Therapeutics, Inc.  100.00 %$ 0.324 $ 0.324 
Innoviva, Inc.  100.00 %$ 58.562 $ 58.562 
Threshold Pharmaceuticals Inc  100.00 %$ 3.000 $ 3.000 
Stemline Therapeutics Inc  100.00 %$ 0.299 $ 0.299 
Steadymed Ltd.  100.00 %$ 0.319 $ 0.319 
Titan Pharmaceuticals Inc  100.00 %$ 0.077 $ 0.077 
Tetraphase Pharmaceuticals Inc  100.00 %$ 1.586 $ 1.586 
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BSC's Profile

Stock Price

BSC's Financials

BSC's Expectations

Business Description

Fundamentals

Charts & Quotes

BSC's News

Suppliers

BSC's Competitors

Customers & Markets

Economic Indicators

BSC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com